Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Glocalink

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$529K
Portfolio companies 14
Rounds per year 1.17
Lead investments 0
Key employees Soon
Stages of investment
Seed

Areas of investment

  • Health Care
  • Robotics
  • Medical Device
  • Biotechnology
  • Developer Platform

Funds with similar focus

Funds from Japan
Funds with similar focus located in Japan:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
aSTART Chiyoda, Japan
Capital A Partners Charleston, South Carolina, United States
CloudAlpha Tech Fund China, Hong Kong, Hong Kong Island
Crosspoint Venture Partners California, Redwood City, United States
CSHVC China, Fujian, Hunan
Enzen Global Solutions Bangalore, India, Karnataka
H. Capital Central, Central Region, Singapore
Innovatemap Ventures Indiana, Indianapolis, United States
JMAR Japan, Tokyo
Orolia Group -
Recurring Capital Partners Austin, Texas, United States
Rio Bravo Brazil, São Paulo, Sao Paulo
SAM Group Greenville, South Carolina, United States
Silk Road Fund Beijing, Beijing, China
Somerston Group Jersey, St. Helier
Suishi Ziben China, Guangdong, Shenzhen
Tao Venture Partners California, San Diego, United States
Tradewind Capital Amsterdam, Noord-Holland, The Netherlands
Xincheng Investment Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ExtraBold

3D Printing
3D Technology
Manufacturing
$3M01 Apr 2021 Sumida, Japan

ProfilePrint

Artificial Intelligence
Food and Beverage
$740K01 Jan 2021 Singapore, Central, Singapore

Building Material
Construction
Robotics
$1M15 Sep 2020 Kagawa Prefecture

JAPAN HEALTHCARE

Health Care
Social Entrepreneurship
$127K27 Dec 2019 Chiyoda, Japan

SAgri

Agriculture
AgTech
Software
Task Management
15 Jan 2019 Japan, Kyoto Prefecture, Japan

Fermenstation

Biofuel
Biomass Energy
Fossil Fuels
05 Dec 2018 Japan, Japan

VEQTA Japan

Communities
Leisure
Pet
31 Jan 2018 Osaka, Osaka Prefecture, Japan

CellFiber

Biotechnology
Clinical Trials
Medical Device
$44K22 Dec 2017 Chiyoda, Japan

Aba

Health Care
Medical
Medical Device
Robotics
31 Jul 2017 Japan, Fukuoka Prefecture, Japan

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Glocalink?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: